USD0.000æéå€ååŒÂ  (ET)
78.10Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
äž»èŠããŒã¿
4.410å§å€
4.460é«å€
115.36Kåºæ¥é«
æ倱é¡çŽè¿12ã¶æPER
æ倱é¡äºæ³PER
--çŽè¿12ã¶æé
åœ
0.63%売買å転ç
4.370åæ¥çµå€
4.190å®å€
354.73K売買代é
æ倱é¡æ ªäŸ¡åçç
7.12PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-186.78%ç·è³ç£å©çç
5.20052é±é«å€
0.63åºæ¥é«æ¯ç%
-29.02MçŽå©ç
18.20Mæ ªåŒæ°
-1.73851æ ªåœããå©çïŒEPSïŒ
1.43ããŒã¿å€
-758.61%èªå·±è³æ¬å©çç
2.44052é±å®å€
6.18%æ¯ãå¹
--ç²å©çç
78.10Mæ䟡ç·é¡
-6.52ãªã¹ã¯ãªã¿ãŒã³
3.33%ãªã¹ã¯ç
PolyPid Ltd ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
ææšî
ææš
売ã(3)
äžç«(2)
è²·ã(1)
移åå¹³å
売ã(4)
äžç«(0)
è²·ã(2)
財åææšî
EPS
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
PolyPid Ltdã®äŒæ¥æ
å ±î
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
äŒæ¥ã³ãŒãPYPD
äŒæ¥åPolyPid Ltd
æé«çµå¶è²¬ä»»è
ãCEOãAkselbrad (Dikla Czaczkes)
ãŠã§ããµã€ãhttps://www.polypid.com
æ ªäž»çµ±èšî
ãããã質å
PolyPid LtdïŒPYPDïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îPolyPid LtdïŒPYPDïŒã®çŸåšã®æ ªäŸ¡ã¯4.29ã§ãã
PolyPid Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îPolyPid Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯PYPDã§ãã
PolyPid Ltdã®52é±é«å€ã¯ãããã§ããïŒ
îPolyPid Ltdã®52é±é«å€ã¯5.20ã§ãã
PolyPid Ltdã®52é±å®å€ã¯ãããã§ããïŒ
îPolyPid Ltdã®52é±å®å€ã¯2.44ã§ãã
PolyPid Ltdã®æ䟡ç·é¡ã¯ãããã§ããïŒ
îPolyPid Ltdã®æ䟡ç·é¡ã¯78.10Mã§ãã
PolyPid Ltd (PYPD) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãPolyPid LtdïŒPYPDïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯12.00ã§ãã
PolyPid Ltd (PYPD) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îPolyPid LtdïŒPYPDïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-2.09ã§ãã
